[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355822-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-355822-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","impact-of-particulate-matter-25-on-a-mouse-model-of-lung-adenocarcinoma","Impact of particulate matter 2.5 on a mouse model of lung adenocarcinoma","","Lung cancer incidence in never-smokers continues to rise, and air pollution is a key nonsmoking-related driver. This study examines how particulate matter 2.5 (PM2.5) influences type 2 immune signaling and lung fibrosis, focusing on group 2 innate lymphoid cells (ILC2) and Th2 responses, as well as fibroblast activation. In EGFR and KRAS/Trp53 LUAD mouse models, PM2.5 was delivered intranasally across short vs. long exposures and with delayed timing.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impact-of-particulate-matter-25-on-a-mouse-model-of-lung-adenocarcinoma/355822/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impact-of-particulate-matter-25-on-a-mouse-model-of-lung-adenocarcinoma/355822.png","ImageObject",300,407,{"name":42,"@type":43},"eBook King","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about PM2.5 and lung cancer?","Question",{"text":63,"@type":64},"It evaluates whether PM2.5-driven type 2 immune responses and/or PM2.5-induced lung fibrosis promote lung cancer tumorigenesis in mouse models of lung adenocarcinoma.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was PM2.5 administered in the mouse experiments?",{"text":68,"@type":64},"PM2.5 was delivered intranasally to EGFR and KRAS/Trp53 LUAD mouse models, with comparisons across different treatment durations, experimental time points, and delayed versus immediate exposure schedules.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings were observed regarding tumor burden and type 2 immunity?",{"text":72,"@type":64},"PM2.5 did not significantly change lung tumor burden or the type 2 immune response mediated by ILC2 and Th2 cells, in the EGFR and KRAS/Trp53 LUAD models tested.",{"name":74,"@type":61,"acceptedAnswer":75},"How did PM2.5 affect fibrosis-related features and CAFs?",{"text":76,"@type":64},"Long-term exposure to PM2.5 or delayed treatment increased CD90.2+ cancer-associated fibroblasts (CAFs) in lung cancer without altering overall lung cancer burden.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},355822,1790469686,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":113,"preview_page_count":33,"preview_urls":149},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Bektas et al. BMC Pulmonary Medicine (2026) 26:252  \n[https://doi.org/10.1186/s12890-026-04292-1](https://doi.org/10.1186/s12890-026-04292-1)  \nBMC Pulmonary Medicine  \nRESEARCH Open Access  \nImpact of particulate matter 2.5 on a mouse model of lung adenocarcinoma  \nElif Irmak Bektas 1, Aftab Alam 1, Sharon Senchanthisai 1, Shyamananda Singh Mayengbam 1, Emily Mackey2, Emily Spitz3, Shamshad Alam4, Boyko Atanassov4, David W. Goodrich4 and Prasenjit Dey 1*  \nAbstract  \nBackground Over the years, lung cancer incidence in never-smokers has been rising. Air pollution is a nonsmoking-related factor that promotes lung cancer progression. Particulate matter 2.5 (PM2 . 5) is a component of air pollution that is associated with a type 2 immune response mediated by group 2 innate lymphoid cells (ILC2) and T helper 2 (Th2) cells. Furthermore, PM2 .5 can activate fibroblasts, induce the secretion of collagen, and contribute to the development of lung fibrosis. Although type 2 immune response and lung fibrosis are described as protumorigenic in lung cancer, whether PM2 . 5-driven type 2 immune response and/or lung fibrosis promote lung cancer tumorigenesis in mouse models of lung cancer remains unclear. This study investigated the impact of PM2 .5 on the type 2 immune response, lung fibrosis, and lung cancer tumorigenesis in vivo.  \nMethods We treated EGFR and KRAS/Trp53 mouse model s of LUAD intranasally with PM2 . 5, analyzed lung tumor burden and lung fibrosis by histology, and changes in type 2 immune cell (ILC2, Th2) and CAF markers by flow cytometry. Different durations of PM2 . 5 treatment (3-week short-term vs. 6-week long-term), experimental time points (10 weeks vs. 15 weeks), and intervals between the onset of EGFR and KRAS/Trp53 mutations and first exposure to PM2 .5 (3 days vs. 4 weeks delayed) were assessed. Unpaired t-test and One-way ANOVA statistical tests were utilized.  \nResults We found that PM2 .5 did not significantly impact lung tumor burden in EGFR and KRAS/Trp53 mouse model s of LUAD. Notably, PM2 .5 did not significantly affect the type 2 immune response mediated by ILC2 and Th2 cells. However, long-term exposure to PM2 .5 or delayed treatment with PM2 .5 significantly increased the abundance of CD90 .2+ CAFs in lung cancer without impacting lung cancer burden.  \nConclusions In summary, while PM2 .5 did not significantly impact EGFR and KRAS/Trp53 lung tumor burden orthe type 2 immune response, long-term or delayed exposure to PM2 .5 promoted CD90 .2+ CAFs in vivo. This study demonstrates that preclinical modeling of PM2 . 5-driven LUAD requires further validation and consideration of confounding variables to reflect air pollution-associated LUAD observed in humans.  \nKeywords PM2 . 5, LUAD, EGFR, KRAS/Trp53, Type 2 immune response, Th2, ILC2, Lung fibrosis, CAF, CD90 . 2+ CAF  \n*Correspondence:  \nPrasenjit Dey  \n[prasenjit.dey@roswell park.org](prasenjit.dey@roswell park.org)  \n1Department of Immunology, Roswell Park Comprehensive Cancer Center, Elm & Carlton Sts. CGP/BLSC-L5307, Buffalo, NY 14263, USA  \n2Department of Animal Resources, Comparative Oncology Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA  \n3Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA  \n4Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The image","cbCaimrJ2WeWCnTA","https://ap.wps.com/l/cbCaimrJ2WeWCnTA","pdf",8440407,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What question does the study address about PM2.5 and lung cancer?\",\"answer\":\"It evaluates whether PM2.5-driven type 2 immune responses and/or PM2.5-induced lung fibrosis promote lung cancer tumorigenesis in mouse models of lung adenocarcinoma.\"},{\"question\":\"How was PM2.5 administered in the mouse experiments?\",\"answer\":\"PM2.5 was delivered intranasally to EGFR and KRAS/Trp53 LUAD mouse models, with comparisons across different treatment durations, experimental time points, and delayed versus immediate exposure schedules.\"},{\"question\":\"What key findings were observed regarding tumor burden and type 2 immunity?\",\"answer\":\"PM2.5 did not significantly change lung tumor burden or the type 2 immune response mediated by ILC2 and Th2 cells, in the EGFR and KRAS/Trp53 LUAD models tested.\"},{\"question\":\"How did PM2.5 affect fibrosis-related features and CAFs?\",\"answer\":\"Long-term exposure to PM2.5 or delayed treatment increased CD90.2+ cancer-associated fibroblasts (CAFs) in lung cancer without altering overall lung cancer burden.\"}]","Impact of particulate matter 2.5 on a mouse model of lung adenocarcinoma | PDF",1790121188,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/debc0a8b010a6e589c941a0016b098c5.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c4fd7962b1106c9eb0ded9de5dff11a.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/611f0ed2ed3f2eb0b0c63b478385b3e7.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b49cbecb12dc8f7db248ed52463c8395.webp",980,1306]